Control of microglial neurotoxicity by the fractalkine receptor - PubMed (original) (raw)
Comparative Study
doi: 10.1038/nn1715. Epub 2006 Jun 18.
Erik P Pioro, Margaret E Sasse, Volodymyr Kostenko, Sandra M Cardona, Ineke M Dijkstra, Deren Huang, Grahame Kidd, Stephen Dombrowski, RanJan Dutta, Jar-Chi Lee, Donald N Cook, Steffen Jung, Sergio A Lira, Dan R Littman, Richard M Ransohoff
Affiliations
- PMID: 16732273
- DOI: 10.1038/nn1715
Comparative Study
Control of microglial neurotoxicity by the fractalkine receptor
Astrid E Cardona et al. Nat Neurosci. 2006 Jul.
Abstract
Microglia, the resident inflammatory cells of the CNS, are the only CNS cells that express the fractalkine receptor (CX3CR1). Using three different in vivo models, we show that CX3CR1 deficiency dysregulates microglial responses, resulting in neurotoxicity. Following peripheral lipopolysaccharide injections, Cx3cr1-/- mice showed cell-autonomous microglial neurotoxicity. In a toxic model of Parkinson disease and a transgenic model of amyotrophic lateral sclerosis, Cx3cr1-/- mice showed more extensive neuronal cell loss than Cx3cr1+ littermate controls. Augmenting CX3CR1 signaling may protect against microglial neurotoxicity, whereas CNS penetration by pharmaceutical CX3CR1 antagonists could increase neuronal vulnerability.
Comment in
- Fractalkine: moving from chemotaxis to neuroprotection.
Ré DB, Przedborski S. Ré DB, et al. Nat Neurosci. 2006 Jul;9(7):859-61. doi: 10.1038/nn0706-859. Nat Neurosci. 2006. PMID: 16801915 No abstract available.
Similar articles
- Methamphetamine-induced neurotoxicity and microglial activation are not mediated by fractalkine receptor signaling.
Thomas DM, Francescutti-Verbeem DM, Kuhn DM. Thomas DM, et al. J Neurochem. 2008 Jul;106(2):696-705. doi: 10.1111/j.1471-4159.2008.05421.x. Epub 2008 Apr 12. J Neurochem. 2008. PMID: 18410508 Free PMC article. - CX3C chemokine receptor 1 deficiency modulates microglia morphology but does not affect lesion size and short-term deficits after experimental stroke.
van der Maten G, Henck V, Wieloch T, Ruscher K. van der Maten G, et al. BMC Neurosci. 2017 Jan 6;18(1):11. doi: 10.1186/s12868-016-0325-0. BMC Neurosci. 2017. PMID: 28061814 Free PMC article. - Fractalkine receptor regulates microglial neurotoxicity in an experimental mouse glaucoma model.
Wang K, Peng B, Lin B. Wang K, et al. Glia. 2014 Dec;62(12):1943-54. doi: 10.1002/glia.22715. Epub 2014 Jul 2. Glia. 2014. PMID: 24989686 - Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
Merino JJ, Muñetón-Gómez V, Alvárez MI, Toledano-Díaz A. Merino JJ, et al. Curr Alzheimer Res. 2016;13(4):403-12. doi: 10.2174/1567205013666151116125714. Curr Alzheimer Res. 2016. PMID: 26567742 Review. - Fractalkine/CX3CR1 is involved in the cross-talk between neuron and glia in neurological diseases.
Luo P, Chu SF, Zhang Z, Xia CY, Chen NH. Luo P, et al. Brain Res Bull. 2019 Mar;146:12-21. doi: 10.1016/j.brainresbull.2018.11.017. Epub 2018 Nov 26. Brain Res Bull. 2019. PMID: 30496784 Review.
Cited by
- Therapeutic Targets in Innate Immunity to Tackle Alzheimer's Disease.
Serradas ML, Ding Y, Martorell PV, Kulińska I, Castro-Gomez S. Serradas ML, et al. Cells. 2024 Aug 26;13(17):1426. doi: 10.3390/cells13171426. Cells. 2024. PMID: 39272998 Free PMC article. Review. - Specificities of Living Human Microglial Cells.
Milior G, Di Chiano M, Morin-Brureau M. Milior G, et al. Adv Neurobiol. 2024;37:569-578. doi: 10.1007/978-3-031-55529-9_31. Adv Neurobiol. 2024. PMID: 39207713 - Microglia in Neurodegenerative Diseases.
Awogbindin I, Wanklin M, Verkhratsky A, Tremblay MÈ. Awogbindin I, et al. Adv Neurobiol. 2024;37:497-512. doi: 10.1007/978-3-031-55529-9_27. Adv Neurobiol. 2024. PMID: 39207709 Review. - Role of Microglia in Stroke.
Cipriani R, Domerq M, Martín A, Matute C. Cipriani R, et al. Adv Neurobiol. 2024;37:405-422. doi: 10.1007/978-3-031-55529-9_23. Adv Neurobiol. 2024. PMID: 39207705 Review. - Aging Microglia and Their Impact in the Nervous System.
von Bernhardi R, Eugenín J. von Bernhardi R, et al. Adv Neurobiol. 2024;37:379-395. doi: 10.1007/978-3-031-55529-9_21. Adv Neurobiol. 2024. PMID: 39207703 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials